Medchem (P.R.), Inc. - Page 2




                                        - 2 -                                         
               reported as its primary source of income receipts from                 
               the sale of Avitene.  P-PR deducted from those receipts                
               amounts that it paid to P-USA and A for labor that they                
               expended on Avitene’s manufacturing process.  P-PR                     
               claimed on its 1992 Federal income tax return that it                  
               was entitled to a $1,993,264 Puerto Rico and possession                
               tax credit under sec. 936(a), I.R.C.  Ps argue that P-                 
               PR met the “active conduct of a trade or business                      
               within a [U.S.] possession” requirement of sec.                        
               936(a)(2)(B), I.R.C., by virtue of:  (1) A’s activities                
               in Puerto Rico, (2) the fact that A manufactured                       
               Avitene using P-PR’s raw materials and equipment, (3)                  
               the fact that P-PR continued to own the raw materials                  
               from the time that it received them until the time that                
               it sold them in their manufactured form as Avitene, and                
               (4) the fact that P-PR paid P-USA and A for the cost of                
               their labor connected to the Avitene manufacturing                     
               process.                                                               
                    Held: P-PR did not actively conduct a trade or                    
               business in Puerto Rico as required by sec.                            
               936(a)(2)(B), I.R.C.; i.e., P-PR did not participate                   
               regularly, continually, extensively, and actively in                   
               the management and operation of a profit-motivated                     
               activity in that possession.                                           


               David A. Hickerson, for petitioners.                                   
               Theodore J. Kletnick, Alan S. Kline, George Curran, Jennifer           
          Allan Kassabian, Marie E. Small, and Melanie A. Garger, for                 
          respondent.                                                                 

                                       OPINION                                        

               LARO, Judge:  These consolidated cases were submitted to the           
          Court without trial.  See Rule 122.  Respondent determined an               
          $815,196 deficiency in the Federal income tax of MedChem (P.R.),            
          Inc. (MedChem P.R.), for its taxable year ended August 31, 1992.            
          Respondent determined a $1,705,019 deficiency in the Federal                
          income tax of MedChem Products, Inc., & Subsidiaries (MedChem               





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  Next

Last modified: May 25, 2011